These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 21267014)

  • 21. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens.
    Arrenberg P; Halder R; Kumar V
    J Cell Physiol; 2009 Feb; 218(2):246-50. PubMed ID: 18814145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer T cell anergy, co-stimulatory molecules and immunotherapeutic interventions.
    Singh AK; Gaur P; Das SN
    Hum Immunol; 2014 Mar; 75(3):250-60. PubMed ID: 24373798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invariant NKT cells as novel targets for immunotherapy in solid tumors.
    Pilones KA; Aryankalayil J; Demaria S
    Clin Dev Immunol; 2012; 2012():720803. PubMed ID: 23118781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?
    Simoni Y; Diana J; Ghazarian L; Beaudoin L; Lehuen A
    Clin Exp Immunol; 2013 Jan; 171(1):8-19. PubMed ID: 23199318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrinsic defects in the T-cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse.
    Yang Y; Bao M; Yoon JW
    Diabetes; 2001 Dec; 50(12):2691-9. PubMed ID: 11723051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor Responses of Invariant Natural Killer T Cells.
    Altman JB; Benavides AD; Das R; Bassiri H
    J Immunol Res; 2015; 2015():652875. PubMed ID: 26543874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune cell crosstalk in type 1 diabetes.
    Lehuen A; Diana J; Zaccone P; Cooke A
    Nat Rev Immunol; 2010 Jul; 10(7):501-13. PubMed ID: 20577267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
    Gerth E; Mattner J
    Front Immunol; 2019; 10():1449. PubMed ID: 31293596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
    Van Kaer L; Wu L; Parekh VV
    Immunology; 2015 Sep; 146(1):1-10. PubMed ID: 26032048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invariant natural killer T cells and their ligands: focus on multiple sclerosis.
    O'Keeffe J; Podbielska M; Hogan EL
    Immunology; 2015 Aug; 145(4):468-75. PubMed ID: 25976210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testing the NKT cell hypothesis of human IDDM pathogenesis.
    Lee PT; Putnam A; Benlagha K; Teyton L; Gottlieb PA; Bendelac A
    J Clin Invest; 2002 Sep; 110(6):793-800. PubMed ID: 12235110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contrasting roles of NKT cells in tumor immunity.
    Berzofsky JA; Terabe M
    Curr Mol Med; 2009 Aug; 9(6):667-72. PubMed ID: 19689293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How do natural killer T cells help B cells?
    Lang ML
    Expert Rev Vaccines; 2009 Aug; 8(8):1109-21. PubMed ID: 19627191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
    Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
    Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunoregulation by iNKT cells].
    Miyake S
    Yakugaku Zasshi; 2009 Jun; 129(6):649-53. PubMed ID: 19483407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunoregulatory role of CD1d-restricted natural killer T cells in disease.
    van der Vliet HJ; Molling JW; von Blomberg BM; Nishi N; Kölgen W; van den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ
    Clin Immunol; 2004 Jul; 112(1):8-23. PubMed ID: 15207777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.
    Gao B; Radaeva S; Park O
    J Leukoc Biol; 2009 Sep; 86(3):513-28. PubMed ID: 19542050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice.
    Poulton LD; Smyth MJ; Hawke CG; Silveira P; Shepherd D; Naidenko OV; Godfrey DI; Baxter AG
    Int Immunol; 2001 Jul; 13(7):887-96. PubMed ID: 11431419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of Natural Killer T Cells and Natural Killer Cells in Kidney Injury.
    Uchida T; Ito S; Kumagai H; Oda T; Nakashima H; Seki S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.